Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 602  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
   Navigate here  
     Search
     Current Issue
     Submit Article 
     My Preferences 

Follow us on:

Twitter Icon Linkedin Icon Instagram Icon Facebook Icon

 


This article has been cited by
1Beta blockers and cancer prognosis The role of immortal time bias: A systematic review and meta-analysis
Janick Weberpals,Lina Jansen,Prudence R. Carr,Michael Hoffmeister,Hermann Brenner
Cancer Treatment Reviews.2016;47()1
[DOI]
2Use of non-selective -blockers is associated with decreased tumor proliferative indices in early stage breast cancer
Alexa Montoya,Clarissa N. Amaya,Andres Belmont,Nabih Diab,Richard Trevino,Geri Villanueva,Steven Rains,Luis A. Sanchez,Nabeel Badri,Salman Otoukesh,Ali Khammanivong,Danielle Liss,Sarah T. Baca,Renato J. Aguilera,Erin B. Dickerson,Alireza Torabi,Alok K. Dwivedi,Aamer Abbas,Karinn Chambers,Brad A. Bryan,Zeina Nahleh
Oncotarget.2017;8(4)6446
[DOI]
3-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of 3 -adrenoceptors
Massimo Dal Monte,Maura Calvani,Maurizio Cammalleri,Claudio Favre,Luca Filippi,Paola Bagnoli
British Journal of Pharmacology.2019;176(14)2496
[DOI]
Online since 20th March '04
Published by Wolters Kluwer - Medknow